Leerink Partners raises Amgen target price to $464 from $395
AMGN•Leerink Partners raised its target price for Amgen to $464 from $395.
Related News
Thomson Reuters target price raised by National Bank of Canada to C$190 from C$180
TRI•
Asia hopes Democrats can curb Trump's Iran war and tariffs: Russell
SPY•
Investors poised for gridlock with Trump as Democrats projected to sweep Congress
SPY•
Ball Corp: JPMorgan cuts to neutral from overweight
BALL•
JPMorgan cuts LendingTree target price to $40 from $48
TREE•